secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2024-09-06T23:59:59+00:00
Accession:  0001193125-24-215218
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics receives Nasdaq delisting notice; plans appeal to stay listing
--------------------------------------------------------------------------------

- Nasdaq notified on Sept 5, 2024 that company failed to regain compliance with minimum $2.5M stockholders' equity rule.
- Company intends to timely appeal, which automatically stays suspension/delisting pending hearing.
- Prior disclosure: stockholders' equity was ($1.348M) as of Dec 31, 2023.
- No assurance that Nasdaq Hearings Panel will grant continued listing or extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524215218/0001193125-24-215218-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524215218/d821033d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-215218

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer